QT-prolonging class I drug, disopyramide, does not aggravate but suppresses adrenaline-induced arrhythmias. Comparison with cibenzoline and pilsicainide-Reference-Cited by-同舟云学术

QT-prolonging class I drug, disopyramide, does not aggravate but suppresses adrenaline-induced arrhythmias. Comparison with cibenzoline and pilsicainide

Published:2000-07 Issue:2-3 Volume:400 Page:263-269
ISSN:0014-2999
Container-title:European Journal of Pharmacology
language:en
Short-container-title:European Journal of Pharmacology

Author:

Miyamoto Shigeki,Zhu Bing-Mei,Teramatsu Tsuyoshi,Aye Nu Nu,Hashimoto Keitaro

Publisher

Elsevier BV

Subject

Pharmacology

Reference22 articles.

1. How to evaluate class III antiarrhythmic drug efficacy clinically: the benefits and shortcomings of the invasive approach;Borggrefe;J. Cardiovasc. Pharmacol.,1992

2. Total and free disopyramide by fluorescence polarization immunoassay and relationship between free fraction and alpha-1 acid glycoprotein;Chen;Clin. Chim. Acta,1987

3. Antiarrhythmic effects of bisaramil in canine models of ventricular arrhythmia;Haruno;Eur. J. Pharmacol.,1993

4. The mechanism of sensitization of the ventricle to epinephrine by halothane;Hashimoto;Am. Heart J.,1972

5. Canine-effective plasma concentrations of antiarrhythmic drugs on the two-stage coronary ligation arrhythmia;Hashimoto;J. Pharmacol. Exp. Ther.,1982

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Solifenacin linked QT interval prolongation and torsades de pointes;Therapeutic Advances in Drug Safety;2017-04-10

2. Assessment of drug-induced proarrhythmias due to pilsicainide in patients with atrial tachyarrhythmias;Journal of Arrhythmia;2016-12

3. Pharmacokinetics of Pilsicainide Hydrochloride for Injection in Healthy Chinese Volunteers: A Randomized, Parallel-Group, Open-Label, Single-Dose Study;Clinical Therapeutics;2014-02

4. An open-label, single-dose, parallel-group, dose-increasing study comparing the pharmacokinetics and tolerability of pilsicainide hydrochloride in healthy Korean and Japanese male subjects;Clinical Therapeutics;2009-03

5. Arrhythmia Models for Drug Research: Classification of Antiarrhythmic Drugs;Journal of Pharmacological Sciences;2007